MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland · Delayed Price · Currency is CHF 2.120
-0.645 (-23.33%)
At close: Dec 19, 2025
MindMaze Therapeutics Holding Company Description
NeuroX Group SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
The company was incorporated in 2025 and is based in Lausanne, Switzerland.
MindMaze Therapeutics Holding SA
| Country | Switzerland |
| Founded | 2025 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Alexandre Capet |
Contact Details
Address: Chemin de Roseneck 5 Lausanne, 1006 Switzerland |
Stock Details
| Ticker Symbol | MMTX |
| Exchange | SIX Swiss Exchange |
| Reporting Currency | CHF |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Alexandre Capet | Chief Executive Officer |
| Jeremy Meinen | Chief Financial Officer |